Prolonged treatment with three-weekly docetaxel plus daily prednisolone for metastatic castration-resistant prostate cancer: a multicenter, phase II, open-label, non-comparative, extension study in Japan

Author： Nishimura Kazuo  

Publisher： Springer Publishing Company

ISSN： 1341-9625

Source： International Journal of Clinical Oncology, Vol.18, Iss.2, 2013-04, pp. : 306-313

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A phase II study of the antisense oligonucleotide GTI-2040 plus docetaxel and prednisone as first-line treatment in castration-resistant prostate cancer

By Sridhar Srikala   Canil Christina   Chi Kim   Hotte Sebastien   Ernst Scott   Wang Lisa   Chen Eric   Juhasz Agnes   Yen Yun   Murray Peter   Zwiebel James   Moore Malcolm  

Cancer Chemotherapy and Pharmacology, Vol. 67, Iss. 4, 2011-04 ,pp. : 927-933

Springer Publishing Company

Access to resources Recommend Favorite

Phase II Trial Assessing Granulocyte-macrophage—Colony Stimulating Factor, Ketoconazole Plus Mitoxantrone in Metastatic Castration-resistant Prostate Cancer Progressing After Docetaxel Treatments

By Amato Robert J.   Saxena Somyata   Stepankiw Mika  

Cancer Investigation, Vol. 31, Iss. 3, 2013-03 ,pp. : 177-182

Informa Healthcare

Access to resources Recommend Favorite

Weekly low-dose docetaxel combined with estramustine and dexamethasone for Japanese patients with metastatic castration-resistant prostate cancer

By Hatano Koji   Nishimura Kazuo   Nakai Yasutomo   Yoshida Takahiro   Sato Mototaka   Kawashima Atsunari   Mukai Masatoshi   Nagahara Akira   Uemura Motohide   Oka Daizo   Nakayama Masashi   Takayama Hitoshi   Shimizu Kiyonori   Meguro Norio   Tanigawa Tsuyoshi   Yamaguchi Seiji   Tsujimura Akira   Nonomura Norio  

International Journal of Clinical Oncology, Vol. 18, Iss. 4, 2013-08 ,pp. : 704-710

Springer Publishing Company

Access to resources Recommend Favorite

Docetaxel in combination with estramustine and prednisolone for castration-resistant prostate cancer

By Kuramoto Tomomi   Inagaki Takeshi   Fujii Reona   Sasaki Yumiko   Nishizawa Satoshi   Nanpo Yoshihito   Matusmura Nagahide   Kohjimoto Yasuo   Hara Isao  

International Journal of Clinical Oncology, Vol. 18, Iss. 5, 2013-10 ,pp. : 890-897

Springer Publishing Company

Access to resources Recommend Favorite

Raltitrexed plus weekly oxaliplatin as first-line chemotherapy in metastatic colorectal cancer: A multicenter non-randomized phase II study

By Santini Daniele   Massacesi Cristian   D’Angelillo Rolando   Marcucci Fabiana   Campisi Costantino   Vincenzi Bruno   Pilone Alberta   Bianco Vincenzo   Bonsignori Maurizio   Tonini Giuseppe  

Medical Oncology, Vol. 21, Iss. 1, 2004-03 ,pp. : 59-66

Humana Press, Inc

Access to resources Recommend Favorite